搜索临床试验以：2nd line ART ( Zidovudine 300mg BID Lamivudine 150mg BID or Tenofovir DF 300mg QD Lamividine 300
总计6个结果
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp & Dohme LLC; Janssen... 和其他合作者终止
-
Immunomolecular Therapeutics, Inc.WCCT Global完全的
-
University of Colorado, DenverNational Institute of Allergy and Infectious Diseases (NIAID); University of Hawaii完全的
-
Rhonda BrandNational Institute of Allergy and Infectious Diseases (NIAID)完全的